VitaSpring Biomedical Co. Ltd. (VITASPRING BIOMEDICAL CO LTD) Aktie
VSBC
GeschlossenVITASPRING BIOMEDICAL CO LTD
Market Cap
$2,298,033
Über VitaSpring Biomedical Co. Ltd. (VITASPRING BIOMEDICAL CO LTD) Aktie
VitaSpring Biomedical Co. Ltd., a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. The company focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications. It is also involved in the development of cell medical treatment. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is based in Riverside, California.
Unternehmensinformationen
92507 Riverside, United States
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.